RevOps Squared
Ray brought three decades of experience in subscription software to the founding of RevOps Squared. With two CEO tenures, five exits (three strategic, two private equity, and one IPO), and multiple leadership roles across marketing, sales, services, and customer success, he had accumulated what he calls "a lot of scars of what I did wrong." The insight was simple but powerful: existing SaaS benchmarks were too generic. A $5 million ARR company with a $25k ACV selling to enterprises needs different metric targets than a $5M company selling $1k seats to SMBs, yet all were being measured against the same standards. Ray created RevOps Squared to bridge this gap—using external benchmarks coupled with internal metrics to drive better decision-making.
Ray developed a comprehensive SaaS performance metrics framework centered on five enterprise value pillars: capital efficiency, operational efficiency, customer acquisition, customer retention, and customer expansion. He identified six core metrics that matter most: Rule of 40, CAC payback period, CAC ratio (blended, new, and expansion variants), gross dollar retention, net dollar retention, and CLTV to CAC. Each metric was segmented by business attributes—ACV, ARR size, pricing model (subscription vs. usage-based vs. hybrid)—rather than lumped into broad categories. The platform also included benchmarks calculated from actual company data, with the latest benchmarks published every six months to stay current with market conditions.
Ray launched the product through speaking engagements, including a keynote at SaaSOpen.com, a high-bar conference with over 100 speakers from SaaS companies. This positioning as a thought leader on metrics and enterprise value became the primary customer acquisition channel. He also directed users to RevOpsSquare.com and emphasized the interactive portal where companies could see their metrics against cohorts.
The segmentation by company profile proved to be the core differentiator. By breaking down benchmarks by ACV (1-5k, 5-25k, 25-100k, 100k+), revenue stage (5M, 10M, 15M+), and pricing model, Ray showed founders why their CAC payback might be 22 months (enterprise) versus 12 months (SMB)—and why that's okay. He also introduced the CAC ratio metric (especially expansion CAC ratio at 69 cents median) to show founders they should invest more in upsell and cross-sell motions. The correlation analysis was striking: Rule of 40 jumped from #5 to #1 as a predictor of enterprise value in 2022-2023, with an R-squared of 0.44, while revenue growth remained close behind at 0.38. This real-time data shifted how investors and founders thought about growth-at-all-costs versus balanced growth with profitability.
RevOps Squared had just kicked off its industry's largest benchmarking program in partnership with 12 companies including Sage, TAC, Maxio, and SaaS Optics. Participation was 100% anonymous, and participating companies received free access to the interactive portal to benchmark against cohorts. The 2023 benchmarking cycle was underway, with updated benchmarks planned for publication in late April to reflect Q4 2022 and Q1 2023 trends. Ray noted that CAC payback period had already decreased about 15% in the first two months of 2023 due to reduced sales and marketing spending, though the sample size was still too small to confirm a trend.
Similar Companies
Active Campaign
$4.2M/moActive Campaign started in 2003 as an on-premise email marketing solution built by Jason Vanderboom to fund his fine arts degree. After 10 years and 8 employees generating a couple million in revenue, he transitioned to a SaaS model starting at $9/month. The company now has over 60,000 customers generating over $50 million annually and employs 330 people, growing primarily through organic adoption, partnerships, and focus on the SMB market despite pressure to move upmarket.
Ahrefs
$3.3M/moAhrefs is a bootstrapped SaaS company providing SEO and backlink analysis tools, currently generating over $40M ARR with 45 employees. After joining in 2015, Tim Solo transformed the blog from 15,000 to 250,000+ monthly Google visitors by shifting from publishing what they wanted to write about to targeting keywords people actually search for, creating high-quality content with direct product integration, and continuously updating articles to accumulate backlinks. The company breaks conventional marketing wisdom by not using customer personas, growth hacks, or detailed analytics—instead focusing entirely on product quality and audience education through blog content.
NutriSense
$3.3M/moNutriSense is a direct-to-consumer metabolic health platform that pairs continuous glucose monitoring devices with proprietary software analytics and dietitian coaching. Launched in September 2019 with pre-sales in keto and Oura Ring Facebook groups, the company grew from under $1M MRR a year ago to $3.3M MRR today (3x growth), with 15,000-16,000 active paying customers and 170 employees. The business has raised $32M in funding across multiple rounds since a $250K seed in early 2020.
Solides
$2.6M/moSolides is the leading HR tech platform for small and medium companies in Brazil, providing talent management software for hiring, development, and retention. Founded in 2010 but pivoted to a subscription model in 2015, the company achieved $31.2M ARR as of March 2023 (100% growth YoY) with 20,000 paying customers managing close to 2 million employees. Alessandro Garcia raised a $100M Series B at an $800M valuation in 2022 and is targeting a $60M run rate by end of 2023, with plans to IPO once reaching $200M in revenue.
Calendly
$2.5M/moTope Awotona founded Calendly after three failed startups taught him the importance of solving real problems rather than chasing money. He spent six months validating the scheduling tool idea by studying competitors' products and user forums, then went all-in by emptying his bank account and hiring engineers in Ukraine. Calendly achieved product-market fit through a freemium model that optimized for invitee experience, growing to 4 million users and $30M ARR largely through organic viral growth and word-of-mouth.